Who is sponsoring NCT03227939?

NCT03227939 is sponsored by Bing Wang.

What drugs are being tested in NCT03227939?

Interventions in NCT03227939: Laparoscopic sleeve gastrectomy（LSG）, Uvulopalatopharyngoplasty(UPPP) and Adenoidectomy/Tonsillectomy.

Is NCT03227939 still recruiting?

NCT03227939 is currently status unknown. Last updated 24 July 2017.

Last reviewed 2017-07-24 · How we verify

NCT03227939

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Combined Surgery on Obstructive Sleep Apnea in Obese Patients: an Open-label Randomized Controlled Clinical Trial

Status unknown NA Last updated 24 July 2017

What this trial tests

NA trial testing Laparoscopic sleeve gastrectomy（LSG） in To Compare the Difference of AHI Variation Between LSG and Combined Surgery in 100 participants. Status unknown.

Timeline

25 July 2017

Primary endpoint
1 February 2020

1 May 2020

Quick facts

Lead sponsor	Bing Wang
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	25 July 2017
Primary completion	1 February 2020
Estimated completion	1 May 2020

Drugs / interventions tested

Laparoscopic sleeve gastrectomy（LSG）
Uvulopalatopharyngoplasty(UPPP) and Adenoidectomy/Tonsillectomy

Conditions studied

To Compare the Difference of AHI Variation Between LSG and Combined Surgery — all drugs for To Compare the Difference of AHI Variation Between LSG and Combined Surgery →

Sponsor

Bing Wang — full company profile →

Who can join

Adults 16 to 65, any sex, with To Compare the Difference of AHI Variation Between LSG and Combined Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is created for compare the difference of AHI variation between LSG and combined surgery on obstructive sleep apnea in obese patients , evaluate the risk of combined surgery and explore the correlative factor of the curative effect.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03227939 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bing Wang
Last refreshed: 24 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03227939.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing